Send the following on WhatsApp
Continue to Chat'Rs 150/dose non-competitive price, not sustainable': Bharat Biotech defends higher pricing of Covaxin - Times of India https://www.indiafinancenews.com/rs-150-dose-non-competitive-price-not-sustainable-bharat-biotech-defends-higher-pricing-of-covaxin-times-of-india/